The effects of dietary weight loss with or without exercise training on liver enzymes in obese metabolic syndrome subjects

Diabetes, Obesity and Metabolism

Volumn 14, Issue 2, 2012, Pages 139-148

  Straznicky, N E ^a   Lambert, E A ^a,b   Grima, M T ^a   Eikelis, N ^a   Nestel, P J ^a   Dawood, T ^a   Schlaich, M P ^a,b   Masuo, K ^a   Chopra, R ^a   Sari, C I ^a   Dixon, J B ^a,b   Tilbrook, A J ^b   Lambert, G W ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Cardiovascular disease; Exercise; Insulin resistance; Neuropharmacology; Obesity therapy; Weight loss therapy

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SATURATED FATTY ACID; TRIACYLGLYCEROL; URIC ACID;

ABDOMINAL FAT; ADULT; AEROBIC EXERCISE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; BODY WEIGHT; CALORIC RESTRICTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FAT INTAKE; FEMALE; FITNESS; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEART RATE; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; OXYGEN CONSUMPTION; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL; SEDENTARY LIFESTYLE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT REDUCTION;

EID: 84855355353     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2011.01497.x     Document Type: Article

References (41)

1. Riley P, O'Donohue J, Crook M. A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease. J Clin Pathol 2007; 60: 1384-1391.
2. Hsiao PJ, Kuo KK, Shin SJ et al. Significant correlation between severe fatty liver and risk factors for metabolic syndrome. J Gastroeneterol Hepatol 2007; 22: 2118-2123.
3. Hamaguchi M, Kojima T, Takeda N et al. The metabolic syndrome as a predictor of non-alcoholic fatty liver disease. Ann Intern Med 2005; 143: 722-728.
4. Fan JG, Li F, Cai XB, Peng YD, Ao QH, Gao Y. Effects of non-alcoholic fatty liver disease on the development of metabolic disorders. J Gastroeneterol Hepatol 2007; 22: 1086-1091.
5. Targher G, Bertolini L, Poli F et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetes patients. Diabetes 2005; 54: 3541-3546.
6. Vozarova B, Stefan N, Lindsay RS et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002; 51: 1889-1895.
7. Larson-Meyer DE, Newcomer BR, Heilbronn LK et al. Effect of 6-month calorie restriction and exercise on serum liver lipids and liver function. Obesity 2008; 16: 1355-1362.
8. Dixon JB, Bhathal PS, O'Brien PE. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histological improvement. Obes Surg 2006; 16: 1278-1286.
9. Hanley AJG, Williams K, Festa A et al. Elevations in markers of liver injury and risk of type 2 diabetes. The Insulin Resistance Atherosclerosis Study. Diabetes 2004; 53: 2623-2632.
10. Nannipieri M, Gonzales C, Baldi S et al. Liver enzymes, the metabolic syndrome, and incident diabetes. The Mexico City Diabetes Study. Diabetes Care 2005; 28: 1757-1762.
11. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H.γ-Glutamyltransferase as a risk factor for cardiovascular disease mortality. Circulation 2005; 112: 2130-2137.
12. Randle PJ, Hales CN, Garland PB, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; i: 785-789.
13. Benthem L, Keizer K, Wiegman CH et al. Excess portal venous long-chain fatty acids induce syndrome X via HPA axis and sympathetic activation. Am J Physiol Endocrinol Metab 2000; 279: E1286-E1293.
14. Florian JP, Pawelczyk JA. Non-esterified fatty acids increase arterial pressure via central sympathetic activation in humans. Clin Sci 2010; 118: 61-69.
15. Alberti KGMM, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
16. American Gastroenterological Association: Medical Position Statement. Non alcoholic fatty liver disease. Gastroeneterology 2002; 123: 1702-1704.
17. Johnson NA, Sachinwalla T, Walton DW et al. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 2009; 50: 1105-1112
18. Tiikkainen M, Bergholm R, Vehkavaara S et al. Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content. Diabetes 2003; 52: 701-707
19. Promat K, Kleiner DE, Niemeier HM et al. Randomized controlled trial testing the effects of weight loss on non-alcoholic steatohepatitis (NASH). Hepatology 2010; 51: 121-129
20. Straznicky NE, Lambert EA, Nestel PJ et al. Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects. Diabetes 2010; 59: 71-79
21. St. George A, Bauman A, Johnston A, Farrell G, Chey T, George J. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors. J Gastroenterol Hepatol 2009; 24: 399-407
22. Straznicky NE, Grima MT, Lambert GW et al. The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components. J Clin Endocrinol Metab 2011; 96: E503-E508
23. Paradisi G, Smith L, Burtner C et al. Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care 1999; 22: 1310-1317
24. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 1999; 22: 1462-1470
25. Prati D, Taioli E, Zanella A et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002; 137: 1-9
26. Johnson NA, George J. Fitness versus fatness: moving beyond weight loss in non-alcoholic fatty liver disease. Hepatology 2010; 52: 370-381
27. Teixeira-Lemos E, Nunes S, Teixeira F, Reis F. Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties. Cardiovasc Diabetol 2011; 10: 12
28. Haus JM, Solomon TPJ, Marchetti CM, Edmison JM, Gonzalez F, Kirwan JP. Free fatty acid-induced hepatic insulin resistance is attenuated following lifestyle intervention in obese individuals with impaired glucose tolerance. J Clin Endocrinol Metab 2010; 95: 323-327
29. Patel JN, Coppack SW, Goldstein DS, Miles JM, Eisenhofer G. Norepinephrine spillover from human adipose tissue before and after a 72-hour fast. J Clin Endocrinol Metab 2002; 87: 3373-3377
30. Gasteyger C, Larsen TM, Vercruysse F, Astrop A. Effect of a dietary-induced weight loss on liver enzymes in obese subjects. Am J Clin Nutr 2008; 87: 1141-1147
31. Friis R, Vaziri ND, Akbarpour F, Afrasiabi A. Effect of rapid weight loss with supplemented fasting on liver tests. J Clin Gastroeneterol 1987; 9: 204-207
32. Mancia G, Bousquet P, Elghozi JL et al. The sympathetic nervous system and the metabolic syndrome. J Hypertens 2007; 25: 909-920
33. Oben JA, Diehl AM. Sympathetic nervous system regulation of liver repair. Anat Rec 2004; 280A: 874-883
34. Dekker JM, Crow RS, Folsom AR et al. Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study Atherosclerosis Risk in Communities. Circulation 2000; 102: 1239-1244
35. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with non-alcoholic fatty liver disease. J Clin Invest 2005; 115: 1343-1351
36. Papandreou D, Rousso I, Malindretos P et al. Are saturated fatty acids and insulin resistance associated with fatty liver in obese children? Clin Nutr 2008; 27: 233-240
37. Kennedy A, Martinez K, Chuang CC, LaPoint K, McIntosh M. Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications. J Nutr 2009; 139: 1-4
38. Field CJ, Toyomizu M, Clandinin MT. Relationship between dietary fat, adipocyte membrane composition and insulin binding in the rat. J Nutr 1989; 119: 1483-1489
39. Straznicky NE, Howes LG, Barrington VE, Lam W, Louis WJ. Effects of dietary lipid modification on adrenoceptor-mediated cardiovascular responsiveness and baroreflex sensitivity in normotensive subjects. Blood Press 1997; 6: 96-102
40. Uslan I, Acarturk G, Karaka E et al. The effects of weight loss on normal transaminase levels in obese patients. Am J Med 2007; 334: 327-330
41. Bellentani S, Saccoccio G, Masutti F et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000; 132: 112-117